PubRank

Daniel Walcher

Author PubWeight™ 19.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. J Am Coll Cardiol 2005 1.60
2 Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients. Circulation 2005 1.42
3 C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004 1.27
4 CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling. J Clin Invest 2012 1.11
5 Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol 2006 1.07
6 Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes 2004 1.01
7 Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study. Eur J Radiol 2010 0.89
8 Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration. Mediators Inflamm 2010 0.89
9 Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol 2005 0.89
10 Proinflammatory effects of C-Peptide in different tissues. Int J Inflam 2012 0.87
11 Vascular effects of PPARgamma activators - from bench to bedside. Prog Lipid Res 2007 0.85
12 Glucagon-like peptide-1(1-37) inhibits chemokine-induced migration of human CD4-positive lymphocytes. Cell Mol Life Sci 2010 0.85
13 Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up. Int J Cardiovasc Imaging 2010 0.84
14 C-peptide: a new mediator of atherosclerosis in diabetes. Mediators Inflamm 2012 0.82
15 C-peptide promotes lesion development in a mouse model of arteriosclerosis. J Cell Mol Med 2012 0.81
16 Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study. Diab Vasc Dis Res 2010 0.81
17 C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus? Exp Diabetes Res 2008 0.79
18 Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterol 2009 0.77
19 Blood oxygen level-dependent magnetic resonance imaging using T2-prepared steady-state free-precession imaging in comparison to contrast-enhanced myocardial perfusion imaging. Int J Cardiol 2009 0.77
20 Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imaging. Int J Cardiol 2010 0.77
21 C-peptide induces human renal mesangial cell proliferation in vitro, activating Src-kinase, PI-3 kinase and ERK1/2. Mol Cell Endocrinol 2012 0.76
22 Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension. Diabetes Res Clin Pract 2010 0.76
23 Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery disease. Coron Artery Dis 2016 0.75
24 Percutaneous Mitral Valve Repair With the MitraClip in Primary Compared With Secondary Mitral Valve Regurgitation Using the Mitral Valve Academic Research Consortium Criteria. J Invasive Cardiol 2017 0.75
25 Neoplastic pericardial effusion induces functional nonvalvular mitral valve stenosis. J Am Coll Cardiol 2010 0.75